Fenofibrate is not a controlled substance. It carries no DEA scheduling, meaning it is not classified alongside drugs with abuse or dependence potential like opioids, benzodiazepines, or stimulants. Fenofibrate is a prescription medication used to lower cholesterol and triglycerides, and it belongs to a class of drugs called antilipemic agents.
What “Not a Controlled Substance” Means for You
The Drug Enforcement Administration (DEA) assigns controlled substance schedules (I through V) to drugs that carry a risk of misuse, addiction, or physical dependence. Fenofibrate has no such designation. It works by speeding up the body’s natural processes for removing cholesterol, with no effect on mood, alertness, or the brain’s reward system. There is no potential for a “high” or habit formation.
In practical terms, this makes prescribing and refilling fenofibrate simpler than it would be for a controlled medication. Your doctor can authorize multiple refills on a single prescription, and you won’t face the tighter limits that apply to controlled drugs (like needing a new prescription each month or showing ID at the pharmacy). Depending on your state, a standard prescription for a non-controlled drug like fenofibrate is valid for six months to one year from the date it was written. After that period, or once all authorized refills are used, your pharmacist will need a new authorization from your doctor.
Why Fenofibrate Still Requires a Prescription
Even though fenofibrate isn’t controlled, it isn’t available over the counter. It requires a prescription because it affects liver function, kidney function, and blood lipid levels in ways that need medical monitoring. Your doctor will typically check blood work before starting the medication and again at intervals of four to eight weeks to see how your lipid levels respond and to watch for side effects.
Fenofibrate is also not appropriate for everyone. People with severe kidney impairment, active liver disease, or gallbladder problems generally should not take it. For those with mild to moderate kidney issues, doctors usually start at a lower dose and monitor closely before making adjustments. These are the kinds of safety considerations that keep fenofibrate behind the pharmacy counter, even without a controlled substance label.
What Fenofibrate Is Prescribed For
Fenofibrate is FDA-approved for two main uses, both as an add-on to diet changes rather than a replacement for them. The first is lowering LDL (“bad”) cholesterol and raising HDL (“good”) cholesterol in adults with high cholesterol or a mix of lipid abnormalities. The second is treating severely high triglycerides, which at extreme levels can trigger pancreatitis, a painful and potentially dangerous inflammation of the pancreas.
Before prescribing fenofibrate, doctors typically expect patients to address lifestyle factors first: diet, exercise, weight management, and alcohol intake. Conditions that can drive lipid problems on their own, like an underactive thyroid or poorly managed diabetes, should also be treated. Fenofibrate enters the picture when these steps aren’t enough on their own.
Available Forms and Typical Dosing
Fenofibrate comes in several brand-name and generic versions, sold as both capsules and tablets. The doses vary by formulation because different versions are absorbed differently. For high cholesterol, common starting doses range from 120 to 160 mg once daily (tablets) or 130 to 200 mg once daily (capsules), taken with a meal. For high triglycerides, doctors often start at a lower dose and adjust upward based on blood work results.
You take fenofibrate once a day, which keeps the routine straightforward. If your kidney function is reduced, expect to start at a lower dose so your doctor can gauge how your body handles the drug before increasing it.
Recent Regulatory Updates
One brand of fenofibrate, Fenoglide, was discontinued from the market, but the FDA confirmed in 2026 that this was not due to safety or effectiveness concerns. Generic versions referencing that product can still be approved and sold. The core takeaway: fenofibrate remains an FDA-approved, widely available medication with no change to its non-controlled status.